Shanghai Reinovax Biologics Co.,ltd

This is an early safety study testing a new pneumonia vaccine designed to protect against 24 different strains of the bacteria. It will involve 230 healthy children and teenagers, aged from 6 weeks to 17 years old. The main goal is to check if the vaccine is safe and to see how w…

This study is testing a new vaccine designed to protect against 24 strains of pneumococcal bacteria, which can cause pneumonia and other serious infections. It will involve 992 healthy Chinese adults aged 18 and older to see how safe the vaccine is and how well it triggers an imm…